News on L-Lysine_6-Transaminase from BioPortfolio.com http://www.BioPortfolio.com Consolidated L-Lysine_6-Transaminase news from BioPortfolio.com Wed, 10 Feb 2010 04:10:52 GMT en Lysine methylation regulates the pRb tumour suppressor proteinhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4031088&HITNO=0&MSIZE=9&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=L-Lysine_6-Transaminase&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4031088&THISHREF=http://c.moreover.com/click/here.pl%3fz2533985204%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4031088&HITNO=0&MSIZE=9&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=L-Lysine_6-Transaminase&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4031088&THISHREF=http://c.moreover.com/click/here.pl%3fz2533985204%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comOncogene: Sirnaomics Licenses Polypeptide Nanoparticle Technology for Its siRNA Therapeutic Product Developmenthttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3938221&HITNO=1&MSIZE=9&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=L-Lysine_6-Transaminase&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3938221&THISHREF=http://c.moreover.com/click/here.pl%3fz2483850396%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3938221&HITNO=1&MSIZE=9&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=L-Lysine_6-Transaminase&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3938221&THISHREF=http://c.moreover.com/click/here.pl%3fz2483850396%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmacy Choice: Sirnaomics certifies polypeptide nanoparticle technologyhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3922676&HITNO=2&MSIZE=9&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=L-Lysine_6-Transaminase&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3922676&THISHREF=http://c.moreover.com/click/here.pl%3fz2476106389%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3922676&HITNO=2&MSIZE=9&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=L-Lysine_6-Transaminase&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3922676&THISHREF=http://c.moreover.com/click/here.pl%3fz2476106389%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNews-Medical.Net: Sirnaomics Licenses Polypeptide Nanoparticle Technology for Its siRNA Therapeutic Product Developmenthttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3919697&HITNO=3&MSIZE=9&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=L-Lysine_6-Transaminase&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3919697&THISHREF=http://c.moreover.com/click/here.pl%3fz2473561991%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3919697&HITNO=3&MSIZE=9&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=L-Lysine_6-Transaminase&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3919697&THISHREF=http://c.moreover.com/click/here.pl%3fz2473561991%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comKOTA Territory News: Sirnaomics Licenses Polypeptide Nanoparticle Technology for Itshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3907119&HITNO=4&MSIZE=9&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=L-Lysine_6-Transaminase&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3907119&THISHREF=http://c.moreover.com/click/here.pl%3fz2467278108%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3907119&HITNO=4&MSIZE=9&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=L-Lysine_6-Transaminase&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3907119&THISHREF=http://c.moreover.com/click/here.pl%3fz2467278108%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comUlitzer: Sirnaomics Licenses Polypeptide Nanoparticle Technology For Its siRNA Therapeutic Product Developmenthttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3906016&HITNO=5&MSIZE=9&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=L-Lysine_6-Transaminase&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3906016&THISHREF=http://c.moreover.com/click/here.pl%3fz2466613781%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3906016&HITNO=5&MSIZE=9&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=L-Lysine_6-Transaminase&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3906016&THISHREF=http://c.moreover.com/click/here.pl%3fz2466613781%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmaceutical Online: Sirnaomics Licenses Polypeptide Nanoparticle Technology for Its siRNA Therapeutic Product Developmenthttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3903580&HITNO=6&MSIZE=9&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=L-Lysine_6-Transaminase&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3903580&THISHREF=http://c.moreover.com/click/here.pl%3fz2465266345%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3903580&HITNO=6&MSIZE=9&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=L-Lysine_6-Transaminase&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3903580&THISHREF=http://c.moreover.com/click/here.pl%3fz2465266345%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Live: Sirnaomics Licenses Polypeptide Nanoparticle Technology for Its siRNA Therapeutic Product Developmenthttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3901640&HITNO=7&MSIZE=9&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=L-Lysine_6-Transaminase&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3901640&THISHREF=http://c.moreover.com/click/here.pl%3fz2464416275%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3901640&HITNO=7&MSIZE=9&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=L-Lysine_6-Transaminase&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3901640&THISHREF=http://c.moreover.com/click/here.pl%3fz2464416275%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFreshnews.com: Sirnaomics Licenses Polypeptide Nanoparticle Technology for Its siRNA Therapeutic Product Developmenthttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3901379&HITNO=8&MSIZE=9&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=L-Lysine_6-Transaminase&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3901379&THISHREF=http://c.moreover.com/click/here.pl%3fz2464320598%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3901379&HITNO=8&MSIZE=9&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=L-Lysine_6-Transaminase&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3901379&THISHREF=http://c.moreover.com/click/here.pl%3fz2464320598%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comGenetic Engineering News: